|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to investigations and disciplinary action by the Texas |
|
Medical Board regarding certain treatments or practices during the |
|
COVID-19 pandemic. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. (a) This Act applies to any person engaged in a |
|
profession regulated by the Texas Medical Board who was |
|
investigated or subject to disciplinary action by the board for: |
|
(1) prescribing or advocating for the use of |
|
ivermectin, hydroxychloroquine, or budesonide in the prevention or |
|
treatment of COVID-19; |
|
(2) making statements regarding the efficacy of masks |
|
in preventing the transmission of COVID-19; or |
|
(3) failing to wear or require others to wear masks |
|
intended to prevent the transmission of COVID-19 in connection with |
|
the person's practice, other than in areas where it was customary to |
|
wear masks before the COVID-19 pandemic. |
|
(b) Not later than December 1, 2023, the Texas Medical Board |
|
shall, for any person described by Subsection (a) of this section: |
|
(1) vacate any disciplinary action imposed; |
|
(2) expunge all records of the board related to the |
|
investigation and disciplinary action; |
|
(3) refund all fines collected from the person; and |
|
(4) reimburse the person for all legal fees incurred |
|
as a result of the investigation or disciplinary action. |
|
SECTION 2. This Act takes effect immediately if it receives |
|
a vote of two-thirds of all the members elected to each house, as |
|
provided by Section 39, Article III, Texas Constitution. If this |
|
Act does not receive the vote necessary for immediate effect, this |
|
Act takes effect September 1, 2023. |